Phathom Pharmaceuticals, Inc. (PHAT) Tops Q3 EPS by 15c
Tweet
Share
E-mail
Get Alerts PHAT Hot Sheet
Join SI Premium – FREE
Phathom Pharmaceuticals, Inc. (NASDAQ: PHAT) reported Q3 EPS of ($1.32), $0.15 better than the analyst estimate of ($1.47). Revenue for the quarter came in at $16.4 million versus the consensus estimate of $12.61 million.
For earnings history and earnings-related data on Phathom Pharmaceuticals, Inc. (PHAT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Amylyx Pharmaceuticals inc. (AMLX) PT Raised to $55 at Guggenheim
- Elauwit Connection, Inc. (ELWT) Misses Q2 EPS by 44c
- e.l.f. Beauty (ELF) PT Raised to $110 at Canaccord
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
